16 Jan Merck Pharmaceuticals is Seeking Participants for a Study
Merck Pharmaceuticals is seeking participants for a study that involves discontinuation of treatment for excessive daytime sleepiness. This important study is in preparation for clinical trials in the development of a new treatment for EDS.
Participants should have a diagnosis of Type 1 Narcolepsy, be over the age of 18 and be willing to travel to designated sites in the USA.
Reimbursement for travel and accommodation costs are provided. If you are interested in the study, please contact the location center closest to you listed in the image below